Holen Sie sich die Stockscreener-App
73.41
0.86%
-0.6818
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$74.09
Offen:
$74.09
24-Stunden-Volumen:
3.16M
Relative Volume:
0.44
Marktkapitalisierung:
$93.10B
Einnahmen:
$386.46B
Nettoeinkommen (Verlust:
$4.49B
KGV:
20.51
EPS:
3.58
Netto-Cashflow:
$4.78B
1W Leistung:
+2.11%
1M Leistung:
+17.58%
6M Leistung:
+13.17%
1J Leistung:
+28.01%
1-Tages-Spanne:
$73.03
$74.45
1-Wochen-Bereich:
$71.11
$74.53
52-Wochen-Spanne:
$43.56
$74.53
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
73.40 | 92.78B | 386.46B | 4.49B | 4.78B | 3.58 |
|
UNH
Unitedhealth Group Inc
|
306.32 | 280.64B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CI
Cigna Group
|
300.60 | 80.31B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
321.63 | 71.75B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
313.84 | 36.52B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Key metrics from CVS Health Corporation’s quarterly dataEarnings Risk Report & High Yield Stock Recommendations - Newser
Can CVS Health Corporation rally from current levelsPortfolio Risk Summary & Technical Pattern Alert System - Newser
63% of Americans Plan Flu Shots: CVS Health Expands with 3-in-1 Testing in 38 States for 2025-2026 - Stock Titan
CVS Health Corporation $CVS Shares Sold by OMERS ADMINISTRATION Corp - MarketBeat
Te Ahumairangi Investment Management Ltd Trims Position in CVS Health Corporation $CVS - MarketBeat
Volatility clustering patterns for CVS Health Corporation2025 Risk Factors & Weekly Setup with ROI Potential - Newser
CVS Health Corporation $CVS Shares Sold by Lansforsakringar Fondforvaltning AB publ - MarketBeat
Is CVS Health Corporation forming a double bottomJuly 2025 Breakouts & Growth Focused Stock Reports - khodrobank.com
How high can CVS Health Corporation stock goWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - Newser
CVS Health Corporation $CVS Shares Sold by Rafferty Asset Management LLC - MarketBeat
Ieq Capital LLC Purchases 180,495 Shares of CVS Health Corporation $CVS - MarketBeat
Cvs Health stock hits 52-week high at 73.26 USD - Investing.com
Former CVS CFO Guertin joins board of Aledade, largest US primary care networkProvidence Business First - The Business Journals
Price momentum metrics for CVS Health Corporation explained2025 Dividend Review & Growth-Oriented Investment Plans - Newser
CVS, Walgreens Limit COVID Vaccines in Some States as Rules Shift - The Herald Palladium
CVS Health Sees Momentum in HCB Segment Amid Utilization Pressure - sharewise.com
CVS Health Sees Momentum In HCB Segment Amid Utilization Pressure - Barchart.com
Cvs Health stock hits 52-week high at 73.26 USD By Investing.com - Investing.com Australia
Connecticut Wealth Management LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS agrees to pay Massachusetts $12M to settle Medicaid overbilling claims - Yahoo Finance
Guggenheim Capital LLC Trims Stock Position in CVS Health Corporation $CVS - MarketBeat
Landscape Capital Management L.L.C. Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
290,000 Shares in CVS Health Corporation $CVS Purchased by Callodine Capital Management LP - MarketBeat
Gamco Investors INC. ET AL Sells 8,857 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Evergreen Capital Management LLC - MarketBeat
Is CVS Health Corporation’s ROIC above industry averageJuly 2025 Rallies & Verified Entry Point Signals - khodrobank.com
CVS Health Corporation (NYSE:CVS) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Trexquant Investment LP Acquires 97,097 Shares of CVS Health Corporation $CVS - MarketBeat
Understanding CVS Health Corporation’s price movementWeekly Trade Analysis & Accurate Buy Signal Alerts - Newser
Gabelli Funds LLC Sells 28,500 Shares of CVS Health Corporation $CVS - MarketBeat
Advanced analytics toolkit walkthrough for CVS Health CorporationTrade Signal Summary & AI Forecasted Entry/Exit Points - Newser
Custom watchlist performance reports with CVS Health CorporationWeekly Trend Recap & High Accuracy Swing Trade Signals - Newser
Using R and stats models for CVS Health Corporation forecastingMarket Growth Summary & Daily Risk Controlled Trade Plans - Newser
CVS Pharmacy Alters COVID-19 Vaccine Access Amid New FDA Guidelines - AInvest
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Can CVS Health's Recent Earnings Weakness Be a Buying Opportunity Amid Stronger Fundamentals? - AInvest
Can CVS Health Corporation's (NYSE:CVS) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price? - Yahoo Finance
480,677 Shares in CVS Health Corporation $CVS Bought by Junto Capital Management LP - MarketBeat
Reversal Confirmed CVS Health Corporation Stock Rallies Above MA2025 Big Picture & Real-Time Stock Price Movement Reports - beatles.ru
What MACD and RSI say about CVS Health CorporationMarket Sentiment Summary & Fast Moving Stock Trade Plans - Newser
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.02%
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):